# BIIB023 Proof-of-Concept Study in Participants With Lupus Nephritis

> **NCT01499355** · PHASE2 · TERMINATED · sponsor: **Biogen** · enrollment: 276 (actual)

## Conditions studied

- Lupus Nephritis

## Interventions

- **BIOLOGICAL:** BIIB023
- **BIOLOGICAL:** Placebo
- **DRUG:** mycophenolate mofetil
- **DRUG:** oral corticosteroids

## Key facts

- **NCT ID:** NCT01499355
- **Lead sponsor:** Biogen
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** TERMINATED
- **Start date:** 2012-07
- **Primary completion:** 2015-12
- **Final completion:** 2015-12
- **Target enrollment:** 276 (ACTUAL)
- **Why stopped:** Results from pre-specified criteria did not demonstrate sufficient efficacy to warrant continuation of the study.
- **Last updated:** 2017-01-18


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT01499355

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT01499355, "BIIB023 Proof-of-Concept Study in Participants With Lupus Nephritis". Retrieved via AI Analytics 2026-06-01 from https://api.ai-analytics.org/clinical/NCT01499355. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*